Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Use of prostate-specific antigen for prostate cancer screening in primary care practice.

Williams RB, Boles M, Johnson RE.

Arch Fam Med. 1995 Apr;4(4):311-5.

PMID:
7536091
2.

Factors influencing use of the prostate-specific antigen screening test in primary care.

Moran WP, Cohen SJ, Preisser JS, Wofford JL, Shelton BJ, McClatchey MW.

Am J Manag Care. 2000 Mar;6(3):315-24.

3.
4.

GP and patient predictors of PSA screening in Australian general practice.

Gattellari M, Young JM, Ward JE.

Fam Pract. 2003 Jun;20(3):294-303.

PMID:
12738699
5.

The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.

Culp S, Porter M.

BJU Int. 2009 Nov;104(10):1457-61. doi: 10.1111/j.1464-410X.2009.08646.x. Epub 2009 Jun 12.

6.

Attitudes and practices of primary care physicians for prostate cancer screening.

Hoffman RM, Papenfuss MR, Buller DB, Moon TE.

Am J Prev Med. 1996 Jul-Aug;12(4):277-81.

PMID:
8874692
7.

Determinants of prostate-specific antigen test use in prostate cancer screening by primary care physicians.

Austin OJ, Valente S, Hasse LA, Kues JR.

Arch Fam Med. 1997 Sep-Oct;6(5):453-8.

PMID:
9305688
8.

Predictors of prostate cancer screening among health fair participants.

Chiu BC, Anderson JR, Corbin D.

Public Health. 2005 Aug;119(8):686-93. Epub 2005 Jan 22.

PMID:
15949522
9.

High rates of prostate-specific antigen testing in men with evidence of benign prostatic hyperplasia.

Meigs JB, Barry MJ, Giovannucci E, Rimm EB, Stampfer MJ, Kawachi I.

Am J Med. 1998 Jun;104(6):517-25.

PMID:
9674713
10.

Prostate cancer screening--a physician survey in Missouri.

Lawson DA, Simoes EJ, Sharp D, Murayi T, Hagan R, Brownson RC, Wilkerson J.

J Community Health. 1998 Oct;23(5):347-58.

PMID:
9793832
11.

Correlates of prostate-specific antigen testing in a large multiethnic cohort.

Haque R, Van Den Eeden SK, Jacobsen SJ, Caan B, Avila CC, Slezak J, Sternfeld B, Loo RK, Quinn VP.

Am J Manag Care. 2009 Nov;15(11):793-9.

12.

Physician and patient predictors of health maintenance visits.

Preisser JS, Cohen SJ, Wofford JL, Moran WP, Shelton BJ, McClatchey MW, Wolfe P.

Arch Fam Med. 1998 Jul-Aug;7(4):346-51.

PMID:
9682688
13.

The impact of informed consent on patient interest in prostate-specific antigen screening.

Wolf AM, Nasser JF, Wolf AM, Schorling JB.

Arch Intern Med. 1996 Jun 24;156(12):1333-6.

PMID:
8651843
14.

Prostate-specific antigen for prostate cancer screening. Do physician characteristics affect its use?

Edlefsen KL, Mandelson MT, McIntosh MW, Andersen MR, Wagner EH, Urban N.

Am J Prev Med. 1999 Jul;17(1):87-90.

PMID:
10429758
15.
16.

Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).

Hoffman RM, Couper MP, Zikmund-Fisher BJ, Levin CA, McNaughton-Collins M, Helitzer DL, VanHoewyk J, Barry MJ.

Arch Intern Med. 2009 Sep 28;169(17):1611-8. doi: 10.1001/archinternmed.2009.262.

PMID:
19786681
17.

Trends in prostate-specific antigen testing from 1995 through 2004.

Farwell WR, Linder JA, Jha AK.

Arch Intern Med. 2007 Dec 10;167(22):2497-502.

PMID:
18071173
18.

Evidence of prostate cancer screening in a UK region.

Gavin A, McCarron P, Middleton RJ, Savage G, Catney D, O'Reilly D, Keane PF, Murray LJ.

BJU Int. 2004 Apr;93(6):730-4.

19.

Predictive properties of serum-prostate-specific antigen testing in a community-based setting.

Jacobsen SJ, Bergstralh EJ, Guess HA, Katusic SK, Klee GG, Oesterling JE, Lieber MM.

Arch Intern Med. 1996 Nov 25;156(21):2462-8.

PMID:
8944739
20.

Racial differences in screening for prostate cancer in the elderly.

Gilligan T, Wang PS, Levin R, Kantoff PW, Avorn J.

Arch Intern Med. 2004 Sep 27;164(17):1858-64.

PMID:
15451760

Supplemental Content

Support Center